Garcia-Carbonero, R., Benavent, M., Jiménez-Fonseca, P., Alonso-Gordoa, T., Teulé, A., Custodio, A., Tafuto, S., Casta, A. L., Spada, F., Lopez, C., Ibrahim, T., Iranzo, V., García-Alfonso, P., González-Flores, E., Silva, M. J. V., Grande, E., Panzuto, F., Crespo, G., Navarro, M., Castellano, D., Hernando, J., Morales-Herrero, R., Álvarez, G. I., Soldevilla, B., Capdevila, J. (2026). Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107). Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01808